Aprio Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Sell
15,500
-419
-3% -$55.2K 0.1% 148
2026
Q1
$2.22M Buy
15,919
+3,629
+30% +$508K 0.12% 116
2025
Q4
$1.9M Buy
12,290
+216
+2% +$26.3K 0.11% 126
2025
Q3
$1.34M Buy
12,074
+352
+3% +$40K 0.13% 104
2025
Q2
$1.3M Sell
11,722
-467
-4% -$49.7K 0.15% 92
2025
Q1
$1.37M Buy
12,189
+4,423
+57% +$456K 0.17% 83
2024
Q4
$717K Buy
7,766
+4,310
+125% +$388K 0.1% 107
2024
Q3
$290K Buy
+3,456
New +$264K 0.05% 204
2024
Q1
Sell
-2,639
Closed -$214K 248
2023
Q4
$214K Sell
2,639
-1,778
-40% -$138K 0.05% 177
2023
Q3
$331K Buy
+4,417
New +$340K 0.09% 109

Other funds holding GILD

Aprio Wealth Management's GILD Position: Q2 2026 in Review

Aprio Wealth Management reduced its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, selling an estimated $55.2K and leaving 15,500 shares worth $1.96M. The position accounts for 0.1% of the portfolio, ranked #148.

Aprio Wealth Management first reported a position in GILD in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.22M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Aprio Wealth Management held 15,500 shares of Gilead Sciences worth $1.96M as of Q2 2026.
  • Aprio Wealth Management sold 419 Gilead Sciences shares in Q2 2026, an estimated $55.2K.
  • Gilead Sciences made up 0.1% of Aprio Wealth Management's portfolio in Q2 2026, its #148 holding.
  • Aprio Wealth Management first reported a position in Gilead Sciences in Q3 2023 and has held it in 10 quarters since.
  • Aprio Wealth Management's Gilead Sciences position peaked at $2.22M in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Aprio Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.